The global market for products used to monitor and treat neonatal and perinatal patients will reach $938 million in 2008 and will grow by 5.1% annually through 2013 reaching over $1,195 million.
Growth in Asia-Pacific and other international markets will be driven by expanding populations and increasing birth rates, greater demand for these products, and the growing availability of low-cost or locally manufactured technologies. Developing countries account for the vast majority of annual births and preterm infants, which are at risk for developing conditions requiring ventilation, warming therapy, jaundice management, and neonatal monitoring. Driven by a growing middle class, demand is increasing for these products, which are well-established in the developed markets of the U.S., Western Europe, and Japan. The growing availability of low-cost and locally manufactured products will continue to drive sales of new units in these countries.
Sales growth will be relatively flat in the U.S. and Europe through 2013. Revenues will be driven by replacement technologies and accessories, and hospitals will continue to prefer devices that offer multiple functions. In infant ventilation, sales will increasingly shift towards comprehensive units capable of treating a full range of patients including neonatal, pediatric, and adult patients. Hybrid warming devices that can be configured as either open warmers or closed incubators will also be preferred. Specialty products such as high-frequency ventilators will also see strong sales growth through 2013. Homecare will represent a growing source for sales of monitoring and jaundice management products.
Source: marketwatch.com Contributed by: DMSMedwire Research JSG Team
Posts
No comments:
Post a Comment